HU3DINKS

HU3DINKS is at the forefront of biotechnology research, dedicated to revolutionizing the field of 3D bioprinting. With a primary focus on developing cutting-edge human tissue-based bioinks, HU3DINKS aims to overcome the limitations associated with synthetic or animal-derived alternatives. HU3DINKS is committed to harnessing the potential of commercially available human tissue-derived materials, converting them into bioinks suitable for various 3D printing technologies, including extrusion- and light-based methods.

Collaboration is central to the mission of HU3DINKS. Working alongside esteemed partners, including THT Biomaterials GmbH, BIO INX, MorphoMed GmbH, UpNano GmbH, and The Research Center in Cooperation with AUVA, LBI for Traumatology, HU3DINKS is driving innovation and making a lasting impact. The company is dedicated to pushing the boundaries of what is possible in 3D bioprinting, contributing to advancements in regenerative medicine, tissue engineering, and personalized healthcare.

HU3DINKS is shaping a future where human tissue-based bioinks pave the way for groundbreaking applications. The company's work promises to redefine possibilities in healthcare and beyond, continually striving to deliver innovative solutions and drive progress in the industry. We invite the management team at HU3DINKS to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.